HOOKIPA Pharma (HOOK)
(Real Time Quote from BATS)
$4.59 USD
-0.15 (-3.17%)
Updated Sep 23, 2024 03:26 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for HOOKIPA Pharma Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -81.58 | -64.92 | -75.67 | -44.08 | -43.04 |
Depreciation/Amortization & Depletion | 3.55 | 3.60 | 4.64 | 4.15 | 1.44 |
Net Change from Assets/Liabilities | 5.33 | 36.11 | -3.86 | -8.12 | -7.38 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 15.18 | 5.20 | 8.87 | 8.71 | 7.24 |
Net Cash From Operating Activities | -57.52 | -20.00 | -66.02 | -39.34 | -41.73 |
Property & Equipment | -4.16 | -5.02 | -12.58 | -2.37 | -2.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -4.16 | -5.02 | -12.58 | -2.37 | -2.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 67.57 | 75.32 | 0.20 | 75.06 | 112.03 |
Issuance (Repayment) of Debt | -1.75 | -2.85 | -0.44 | -1.42 | -2.28 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.15 | -0.20 | 0.00 | -0.22 | 0.00 |
Net Cash from Financing Activities | 65.67 | 72.27 | -0.24 | 73.42 | 109.75 |
Effect of Exchange Rate Changes | 0.09 | -0.73 | 2.57 | -2.11 | -1.03 |
Net Change In Cash & Equivalents | 4.08 | 46.53 | -76.27 | 29.60 | 65.00 |
Cash at Beginning of Period | 113.44 | 66.91 | 143.18 | 113.58 | 48.58 |
Cash at End of Period | 117.52 | 113.44 | 66.91 | 143.18 | 113.58 |
Diluted Net EPS | -8.60 | -9.90 | -23.00 | -16.90 | -24.10 |
Fiscal Year End for HOOKIPA Pharma Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -4.71 | 14.38 | -81.58 | -56.76 | -37.70 |
Depreciation/Amortization & Depletion | 1.35 | 0.64 | 3.55 | 2.27 | 1.79 |
Net Change from Assets/Liabilities | -35.38 | -38.93 | 5.33 | 6.26 | 12.37 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.21 | -0.25 | 15.18 | 1.93 | 1.36 |
Net Cash From Operating Activities | -38.53 | -24.16 | -57.52 | -46.30 | -22.18 |
Property & Equipment | -0.16 | -0.12 | -4.16 | -3.74 | -0.72 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.16 | -0.12 | -4.16 | -3.74 | -0.72 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 67.57 | 46.32 | 46.98 |
Issuance (Repayment) of Debt | -1.14 | 0.00 | -1.75 | -1.75 | -1.75 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.14 | -0.14 | -0.15 | -0.15 | -0.15 |
Net Cash from Financing Activities | -1.28 | -0.14 | 65.67 | 44.42 | 45.08 |
Effect of Exchange Rate Changes | -0.20 | -0.16 | 0.09 | 0.27 | 0.39 |
Net Change In Cash & Equivalents | -40.17 | -24.57 | 4.08 | -5.35 | 22.57 |
Cash at Beginning of Period | 117.52 | 117.52 | 113.44 | 113.44 | 113.44 |
Cash at End of Period | 77.35 | 92.96 | 117.52 | 108.10 | 136.01 |
Diluted Net EPS | -1.52 | 1.10 | -2.00 | -1.70 | -2.20 |